Alzheimer's & Dementia·17 SepOperationalizing Alzheimer's disease trials in the era of targeted therapiesReviewInterventionsPaper
Translational Psychiatry·16 SepRegional juxtacortical microstructural changes and gene expression provide insights into neurodegeneration in Alzheimer's diseaseStudy in peopleMechanismsPaper
Frontiers in Neurology·26 AugConsiderations for using amyloid-targeting therapies for the treatment of early symptomatic Alzheimer's diseaseReviewInterventionsPaper
Alzheimer's & Dementia·21 AugBeyond the Cochrane review: Re-evaluating anti-amyloid therapy in Alzheimer's diseaseReviewInterventionsPaper
AAIC 2025 Abstract·8 JanHearing and Speech Perception are Associated with A/T/N Biomarkers of Alzheimer's DiseaseStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·8 JanAssociation of Retinal Perfusion with Plasma Biomarkers of Alzheimer's DiseaseStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·25 DecMultiple‐Dose Results from an Ongoing Phase 1 Study of Mivelsiran, an Investigational RNA Interference Therapeutic Targeting Amyloid‐Beta Precursor Protein for Alzheimer’s DiseaseTrial in peopleInterventionsPaper
AAIC 2025 Abstract·23 DecCorrespondence Between the MIND Diet Adherence Screener and Food Frequency QuestionnaireStudy in peopleBiomarkersPaper